Literature DB >> 24810115

In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes.

Ronny Rüger1, Felista L Tansi2, Markus Rabenhold3, Frank Steiniger4, Roland E Kontermann5, Alfred Fahr6, Ingrid Hilger7.   

Abstract

Molecular and cellular changes that precede the invasive growth of solid tumors include the release of proteolytic enzymes and peptides in the tumor stroma, the recruitment of phagocytic and lymphoid infiltrates and alteration of the extracellular matrix. The reactive tumor stroma consists of a large number of myofibroblasts, characterized by high expression of fibroblast activation protein alpha (FAP). FAP, a type-II transmembrane sialoglycoprotein is an attractive target in diagnosis and therapy of several pathologic disorders especially cancer. In the underlying work, a fluorescence-activatable liposome (fluorescence-quenched during circulation and fluorescence activation upon cellular uptake), bearing specific single-chain Fv fragments directed against FAP (scFv'FAP) was developed, and its potential for use in fluorescence diagnostic imaging of FAP-expressing tumor cells was evaluated by whole body fluorescence imaging. The liposomes termed anti-FAP-IL were prepared via post-insertion of ligand-phospholipid-conjugates into preformed DY-676-COOH-containing liposomes. The anti-FAP-IL revealed a homogeneous size distribution and showed specific interaction and binding with FAP-expressing cells in vitro. The high level of fluorescence quenching of the near-infrared fluorescent dye sequestered in the aqueous interior of the liposomes enables fluorescence imaging exclusively upon uptake and degradation by cells, which results in fluorescence activation. Only FAP-expressing cells were able to take up and activate fluorescence of anti-FAP-IL in vitro. Furthermore, anti-FAP-IL accumulated selectively in FAP-expressing xenograft models in vivo, as demonstrated by blocking experiments using free scFv'FAP. The local tumor fluorescence intensities were in agreement with the intrinsic degree of FAP-expression in different xenograft models. Thus, anti-FAP-IL can serve as a suitable in vivo diagnostic tool for pathological disorders accompanied by high FAP-expression.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FAP; Fluorescence-quenching; Immunoliposomes; NIRF; Optical imaging

Mesh:

Substances:

Year:  2014        PMID: 24810115     DOI: 10.1016/j.jconrel.2014.04.050

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  Vision 20/20: Molecular-guided surgical oncology based upon tumor metabolism or immunologic phenotype: Technological pathways for point of care imaging and intervention.

Authors:  Brian W Pogue; Keith D Paulsen; Kimberley S Samkoe; Jonathan T Elliott; Tayyaba Hasan; Theresa V Strong; Daniel R Draney; Joachim Feldwisch
Journal:  Med Phys       Date:  2016-06       Impact factor: 4.071

2.  Use of single chain antibody derivatives for targeted drug delivery.

Authors:  Yaghoub Safdari; Vahideh Ahmadzadeh; Masoumeh Khalili; Hossein Zarei Jaliani; Vahid Zarei; Vahid Erfani-Moghadam
Journal:  Mol Med       Date:  2016-04-22       Impact factor: 6.354

Review 3.  Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins.

Authors:  Martin C Boonstra; Susanna W L de Geus; Hendrica A J M Prevoo; Lukas J A C Hawinkels; Cornelis J H van de Velde; Peter J K Kuppen; Alexander L Vahrmeijer; Cornelis F M Sier
Journal:  Biomark Cancer       Date:  2016-09-27

4.  Dataset on FAP-induced emergence of spontaneous metastases and on the preparation of activatable FAP-targeting immunoliposomes to detect the metastases.

Authors:  Felista L Tansi; Ronny Rüger; Claudia Böhm; Roland E Kontermann; Ulf K Teichgraeber; Alfred Fahr; Ingrid Hilger
Journal:  Data Brief       Date:  2016-09-03

5.  The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.

Authors:  Peio Errarte; Rosa Guarch; Rafael Pulido; Lorena Blanco; Caroline E Nunes-Xavier; Maider Beitia; Javier Gil; Javier C Angulo; José I López; Gorka Larrinaga
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

Review 6.  Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical Imaging.

Authors:  Nirilanto Ramamonjisoa; Ellen Ackerstaff
Journal:  Front Oncol       Date:  2017-01-31       Impact factor: 6.244

7.  A fast and effective determination of the biodistribution and subcellular localization of fluorescent immunoliposomes in freshly excised animal organs.

Authors:  Felista L Tansi; Ronny Rüger; Ansgar M Kollmeier; Claudia Böhm; Roland E Kontermann; Ulf K Teichgraeber; Alfred Fahr; Ingrid Hilger
Journal:  BMC Biotechnol       Date:  2017-01-18       Impact factor: 2.563

8.  A synthetic urinary probe-coated nanoparticles sensitive to fibroblast activation protein α for solid tumor diagnosis.

Authors:  Xinwei Feng; Qifan Wang; Yuehua Liao; Xie Zhou; Yidan Wang; Wanli Liu; Ge Zhang
Journal:  Int J Nanomedicine       Date:  2017-07-27

9.  Antibody fragments as nanoparticle targeting ligands: a step in the right direction.

Authors:  Daniel A Richards; Antoine Maruani; Vijay Chudasama
Journal:  Chem Sci       Date:  2016-09-16       Impact factor: 9.825

Review 10.  Stromal Targets for Fluorescent-Guided Oncologic Surgery.

Authors:  Martin C Boonstra; Jai Prakash; Cornelis J H Van De Velde; Wilma E Mesker; Peter J K Kuppen; Alexander L Vahrmeijer; Cornelis F M Sier
Journal:  Front Oncol       Date:  2015-11-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.